181 related articles for article (PubMed ID: 23756870)
1. Epithelial expression of FHL2 is negatively associated with metastasis-free and overall survival in colorectal cancer.
Verset L; Tommelein J; Moles Lopez X; Decaestecker C; Mareel M; Bracke M; Salmon I; De Wever O; Demetter P
Br J Cancer; 2013 Jul; 109(1):114-20. PubMed ID: 23756870
[TBL] [Abstract][Full Text] [Related]
2. KLF8 promotes tumorigenesis, invasion and metastasis of colorectal cancer cells by transcriptional activation of FHL2.
Yan Q; Zhang W; Wu Y; Wu M; Zhang M; Shi X; Zhao J; Nan Q; Chen Y; Wang L; Cheng T; Li J; Bai Y; Liu S; Wang J
Oncotarget; 2015 Sep; 6(28):25402-17. PubMed ID: 26320172
[TBL] [Abstract][Full Text] [Related]
3. Tumoral expression of nuclear cofactor FHL2 is associated with lymphatic metastasis in sporadic but not in HNPCC-associated colorectal cancer.
Al-Nomani L; Friedrichs J; Schüle R; Büttner R; Friedrichs N
Pathol Res Pract; 2015 Feb; 211(2):171-4. PubMed ID: 25554651
[TBL] [Abstract][Full Text] [Related]
4. Four and a half LIM domains 2 contributes to the development of human tongue squamous cell carcinoma.
Wang Q; Wang X; Tian X; Tang R; Xu X
J Mol Histol; 2016 Apr; 47(2):105-16. PubMed ID: 26759260
[TBL] [Abstract][Full Text] [Related]
5. FHL2 expression in peritumoural fibroblasts correlates with lymphatic metastasis in sporadic but not in HNPCC-associated colon cancer.
Gullotti L; Czerwitzki J; Kirfel J; Propping P; Rahner N; Steinke V; Kahl P; Engel C; Schüle R; Buettner R; Friedrichs N
Lab Invest; 2011 Dec; 91(12):1695-705. PubMed ID: 21826055
[TBL] [Abstract][Full Text] [Related]
6. FHL2 promotes tubular epithelial-to-mesenchymal transition through modulating β-catenin signalling.
Cai T; Sun D; Duan Y; Qiu Y; Dai C; Yang J; He W
J Cell Mol Med; 2018 Mar; 22(3):1684-1695. PubMed ID: 29193729
[TBL] [Abstract][Full Text] [Related]
7. The four and a half LIM domains 2 (FHL2) regulates ovarian granulosa cell tumor progression via controlling AKT1 transcription.
Hua G; He C; Lv X; Fan L; Wang C; Remmenga SW; Rodabaugh KJ; Yang L; Lele SM; Yang P; Karpf AR; Davis JS; Wang C
Cell Death Dis; 2016 Jul; 7(7):e2297. PubMed ID: 27415427
[TBL] [Abstract][Full Text] [Related]
8. Four and a Half LIM Domains 2 (FHL2) Contribute to the Epithelial Ovarian Cancer Carcinogenesis.
Wang C; Lv X; He C; Davis JS; Wang C; Hua G
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33092075
[TBL] [Abstract][Full Text] [Related]
9. miR-340-FHL2 axis inhibits cell growth and metastasis in ovarian cancer.
Huang Z; Li Q; Luo K; Zhang Q; Geng J; Zhou X; Xu Y; Qian M; Zhang JA; Ji L; Wu J
Cell Death Dis; 2019 May; 10(5):372. PubMed ID: 31068580
[TBL] [Abstract][Full Text] [Related]
10. Increased expression of FHL2 promotes tumorigenesis in cervical cancer and is correlated with poor prognosis.
Jin X; Jiao X; Jiao J; Zhang T; Cui B
Gene; 2018 Aug; 669():99-106. PubMed ID: 29800735
[TBL] [Abstract][Full Text] [Related]
11. High level of FHL2 exacerbates the outcome of non-small cell lung cancer (NSCLC) patients and the malignant phenotype in NSCLC cells.
Li N; Xu L; Zhang J; Liu Y
Int J Exp Pathol; 2022 Jun; 103(3):90-101. PubMed ID: 35366027
[TBL] [Abstract][Full Text] [Related]
12. High FHL2 mRNA expression and its prognostic value in lung cancer.
Jiao Y; Wei J; Li Z; Zhou J; Liu Y
Aging (Albany NY); 2022 Oct; 14(19):7986-8000. PubMed ID: 36227138
[TBL] [Abstract][Full Text] [Related]
13. FHL2 participates in renal interstitial fibrosis by altering the phenotype of renal tubular epithelial cells via regulating the β-catenin pathway.
Zhou SG; Ma HJ; Guo ZY; Zhang W; Yang X
Eur Rev Med Pharmacol Sci; 2018 May; 22(9):2734-2741. PubMed ID: 29771425
[TBL] [Abstract][Full Text] [Related]
14. Suppression of FHL2 expression induces cell differentiation and inhibits gastric and colon carcinogenesis.
Wang J; Yang Y; Xia HH; Gu Q; Lin MC; Jiang B; Peng Y; Li G; An X; Zhang Y; Zhuang Z; Zhang Z; Kung HF; Wong BC
Gastroenterology; 2007 Mar; 132(3):1066-76. PubMed ID: 17383428
[TBL] [Abstract][Full Text] [Related]
15. FHL2 silencing reduces Wnt signaling and osteosarcoma tumorigenesis in vitro and in vivo.
Brun J; Dieudonné FX; Marty C; Müller J; Schüle R; Patiño-García A; Lecanda F; Fromigué O; Marie PJ
PLoS One; 2013; 8(1):e55034. PubMed ID: 23383046
[TBL] [Abstract][Full Text] [Related]
16. The LIM domain protein FHL2 interacts with the NR5A family of nuclear receptors and CREB to activate the inhibin-α subunit gene in ovarian granulosa cells.
Matulis CK; Mayo KE
Mol Endocrinol; 2012 Aug; 26(8):1278-90. PubMed ID: 22734036
[TBL] [Abstract][Full Text] [Related]
17. Regulation of the transcriptional coactivator FHL2 licenses activation of the androgen receptor in castrate-resistant prostate cancer.
McGrath MJ; Binge LC; Sriratana A; Wang H; Robinson PA; Pook D; Fedele CG; Brown S; Dyson JM; Cottle DL; Cowling BS; Niranjan B; Risbridger GP; Mitchell CA
Cancer Res; 2013 Aug; 73(16):5066-79. PubMed ID: 23801747
[TBL] [Abstract][Full Text] [Related]
18. Deletion of FHL2 gene impaired ischemia-induced blood flow recovery by modulating circulating proangiogenic cells.
Huang PH; Chen CY; Lin CP; Wang CH; Tsai HY; Lo WY; Leu HB; Chen JW; Lin SJ; Chu PH
Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):709-17. PubMed ID: 23413425
[TBL] [Abstract][Full Text] [Related]
19. Four-and-a-half LIM protein 2 promotes invasive potential and epithelial-mesenchymal transition in colon cancer.
Zhang W; Jiang B; Guo Z; Sardet C; Zou B; Lam CS; Li J; He M; Lan HY; Pang R; Hung IF; Tan VP; Wang J; Wong BC
Carcinogenesis; 2010 Jul; 31(7):1220-9. PubMed ID: 20460358
[TBL] [Abstract][Full Text] [Related]
20. ADAM-17/FHL2 colocalisation suggests interaction and role of these proteins in colorectal cancer.
Verset L; Tommelein J; Decaestecker C; De Vlieghere E; Bracke M; Salmon I; De Wever O; Demetter P
Tumour Biol; 2017 Mar; 39(3):1010428317695024. PubMed ID: 28349819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
